Four New IPO Listings On August 16: Check Details

In the early afternoon session, domestic benchmark shares fell from record highs. At 55,500 points, the BSE benchmark Sensex was trading 90 points higher. Today, the index reached a new high of 55,680. The Nifty50 on the NSE was up 12 points and hovering around 16,550. The 50-pack index reached a new high of 16,585.

Devyani International, Windlas Biotech, Krsnaa Diagnostics, and Exxaro Tiles are among the four IPOs set to launch on the stock exchanges on Monday, with pre-market discovery prices of Rs 141, Rs 439, Rs 1,005.55, and Rs 126, respectively.

Devyani International IPO Listing

Devyani International, the parent company of KFC, Pizza Hut, and Costa Coffee, had a strong launch on August 16, with the stock trading at a 56 percent premium on the bourses.

It started trading at Rs 141 on the BSE and Rs 140.90 on the NSE, against an issue price of Rs 90 per share.
On August 4, the company opened its Rs 1,838-crore initial public offering for subscription, which concluded on August 6 with a phenomenal 116.71 times subscription, generating bids for 1,313.79 crore equity shares against an offer size of 11.25 crore equity shares.
The offer included a Rs 440 crore new issue and a Rs 1,398 crore offer for sale by investor Dunearn Investments and promoter RJ Corp. The proceeds from the new issue will be used to repay the company's debts as well as for general business objectives.

Krsnaa Diagnostics IPO Listing

Following modest market movement, Krsnaa Diagnostics shares made a lukewarm debut on the public exchanges today. Krsnaa Diagnostics shares opened at Rs 1025 per share, up 7.33 percent from the initial public offering price of Rs 954 per share. Krsnaa Diagnostics' initial public offering (IPO) received a great reaction from investors, with 64.38 times subscription. The company had a market valuation of Rs 3,218.26 crore when it went public.

Krsnaa Diagnostics has joined industry peers Metropolis Healthcare and Dr. Lal Pathlabs Ltd in being listed. Qualified Institutional Buyers (QIBs) subscribed 49.83 times their reserved amount at the IPO, 116.30 times for non-institutional investors, and 42.04 times for retail investors. There was a fresh issue of up to Rs 400 crore and an offer for sale of up to 85,25,520 equity shares in the first public offering (IPO).

Windlas Biotech IPO Listing

Windlas Biotech's stock had a lukewarm market debut on Monday, with the stock trading at Rs 437 on the NSE, a 5% reduction to its issue price of Rs 460.

The stock opened at Rs 439 on the BSE, down 4.56 percent.

The Dehradun-based pharma formulations company's initial public offering (IPO) was held from August 4 to August 6 and sold in the Rs 448-460 range.

It was 22.46 times subscribed, with quotas earmarked for qualified institutional buyers (QIB) receiving 24.40 times subscription, non-institutional investors 15.73 times subscription, and retail individual investors (RIIs) 24.27 times subscription.

Exxaro Tiles IPO Listing

 

Exxaro Tiles' shares made its stock market debut on Monday, trading at a premium of 5% over its issue price of Rs 120.

On both the BSE and the NSE, the stock began trading at Rs 126, a 5% gain above the issue price.

On both markets, it rose 10.25 percent to Rs 132.30 as the trade advanced. The ceramic industry's first initial public offering in more than a decade drew a strong reaction from investors, with the issue being subscribed 10.6 times. From August 4 to 6, the issue was available for public subscription.

Exxaro Tiles specialises in the production and distribution of vitrified tiles, which are mostly used for flooring. The company operates two manufacturing facilities, one in Vadodara and the other in Talod, with a total area of 1.5 lakh square metres.